Providence Therapeutics Holdings Inc.
Quick facts
Phase 3 pipeline
- PTX-COVID19-B · Immunology / Infectious Disease
PTX-COVID19-B is an mRNA vaccine that encodes viral proteins to stimulate immune responses against SARS-CoV-2.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: